ABBV — AbbVie Inc.
—
NYSE ·
Health Care ·
Pharmaceuticals ·
CIK 1551152 ·
Last close
$248.76
Market Cap
$439.59B
52W High
$267.47
52W Low
$202.86
ADV30
5,929,817
Next earnings
2026-10-29
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 16,990,000,000 | 12,699,000,000 | 6,723,000,000 | 3,613,000,000 | 135,115,000,000 | 6,569,000,000 | 141,003,000,000 |
| Mar 2026 | — | — | — | — | — | — | — |
| Dec 2025 | 16,618,000,000 | 12,066,000,000 | 5,809,000,000 | 1,816,000,000 | 133,960,000,000 | 5,229,000,000 | 137,188,000,000 |
| Sep 2025 | 15,776,000,000 | 10,472,000,000 | 4,584,000,000 | 186,000,000 | 133,898,000,000 | 5,629,000,000 | 136,497,000,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$19,507,000,000
Investing CF
$-6,498,000,000
Financing CF
$-12,891,000,000
CapEx
$-1,297,000,000
Dividends Paid
$-11,978,000,000
Buybacks
$-1,505,000,000
EPS Diluted TTM
$3.54
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-17,333,000,000
Inventory
$5,127,000,000
Receivables
$13,824,000,000
ST Investments
$28,000,000
EBIT TTM
$11,615,000,000
Pretax Income TTM
$8,699,000,000
Interest Exp TTM
$2,916,000,000
Analysts
28
Yahoo Snapshot (yfinance, live)
Total Revenue
$64,385,998,848
EBITDA
$30,762,999,808
Free Cash Flow
$16,870,250,496
Enterprise Value
$503,951,097,856
Total Cash
$6,568,999,936
Total Debt
$70,884,999,168
Shares Out
1,767,117,285
Trailing EPS
$3.53
Book Value
$-3.36
ROE
—
ROA
10.5%
Div Yield
2.77%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 61,160,000,000 | 20,091,000,000 | 4,226,000,000 | 133,960,000,000 | 137,188,000,000 | — | 19,030,000,000 |
| Dec 2024 | 56,334,000,000 | 11,894,000,000 | 4,278,000,000 | 135,161,000,000 | 131,797,000,000 | — | 18,806,000,000 |
| Dec 2023 | 54,318,000,000 | 13,535,000,000 | 4,863,000,000 | 134,711,000,000 | 124,314,000,000 | — | 22,839,000,000 |
| Dec 2022 | 58,054,000,000 | 18,814,000,000 | 11,836,000,000 | 138,805,000,000 | 121,518,000,000 | — | 24,943,000,000 |
TTM Snapshot
Revenues TTM
$57,541,000,000
NetIncome TTM
$10,467,000,000
OpCashFlow TTM
$0
Assets (Latest)
$135,161,000,000
Forward EPS
$16.28
Max Pain — expiry 2026-08-21
max pain strike: $240.00 · spot: $250.06 · call oi: 36,460 · put oi: 24,245
Expected Move to 2026-08-21:
±$6.87
(2.75%) —
implied range
$243.19 –
$256.92
· ATM straddle on $250.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| MRK | Merck & Co., Inc. | $327.94B | $132.92 | — |
| JNJ | JOHNSON & JOHNSON | $628.65B | $260.86 | — |
| NVSEF | NOVARTIS AG | $300.12B | $157.90 | — |
| NVS | NOVARTIS AG | $289.52B | $152.32 | — |
| AZN | ASTRAZENECA PLC | $245.82B | $158.50 | — |
News headlines (Yahoo Finance, 1h cache)
Here Are Thursday’s Top Wall Street Analyst Research Calls: Abbott Labs, AbbVie, Akamai Technologies, Five Below, Keurig Dr. Pepper, Salesforce, Stryker, StubHub, and More
2026-08-13 11:53 · Yahoo
Johnson & Johnson vs AbbVie: Safe Dividend vs Higher Yield
2026-08-12 18:30 · Yahoo
AbbVie (ABBV) Wins Canada Reimbursement Backing For Adult Migraine Treatment
2026-08-11 22:15 · Yahoo
AbbVie vs. CVS Health: Which Healthcare Stock Is a Better Buy in 2026?
2026-08-11 20:47 · Yahoo
Pfizer vs AbbVie: What's the Better Dividend Stock for Investors in 2026?
2026-08-11 17:15 · Yahoo
The Energy and Pharma Giants Quietly Funding HDV’s 3% Yield, and How Safe Each One Is
2026-08-12 16:12 · Yahoo
The Sharpest Exchanges From ABBV's Earnings Call
2026-08-13 16:10 · Yahoo
Wolfe Research upgrades Biogen, AbbVie on pipeline strength and valuation
2026-08-13 13:52 · Yahoo
How ABBV Stock Moved Away From Its Peer Group
2026-08-12 20:49 · Yahoo
Amgen Stock And The Price Of A Promise
2026-08-12 19:17 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.